NCT01383330View on ClinicalTrials.gov

A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition

PHASE1UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

megace

800mg

DRUG

DW-ES(A)

625mg

DRUG

DW-ES(B)

625mg

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT01383330 - A Clinical Trial to Evaluate Pharmacokinetics of Daewon DW-ES(A) 625mg/5ml, Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in Healthy Male Volunteers Under Fed Condition | Biotech Hunter | Biotech Hunter